209 related articles for article (PubMed ID: 12391285)
1. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.
Wick M; Hurteau G; Dessev C; Chan D; Geraci MW; Winn RA; Heasley LE; Nemenoff RA
Mol Pharmacol; 2002 Nov; 62(5):1207-14. PubMed ID: 12391285
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Pang L; Nie M; Corbett L; Knox AJ
J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells.
Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
J Pharmacol Exp Ther; 2002 Jul; 302(1):18-25. PubMed ID: 12065695
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
7. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway.
DeCicco KL; Tanaka T; Andreola F; De Luca LM
Carcinogenesis; 2004 Oct; 25(10):1805-12. PubMed ID: 15205358
[TBL] [Abstract][Full Text] [Related]
8. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
[TBL] [Abstract][Full Text] [Related]
9. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
Hawcroft G; Gardner SH; Hull MA
J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
[TBL] [Abstract][Full Text] [Related]
12. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling.
Adamson DJ; Frew D; Tatoud R; Wolf CR; Palmer CN
Mol Pharmacol; 2002 Jan; 61(1):7-12. PubMed ID: 11752200
[TBL] [Abstract][Full Text] [Related]
13. Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.
Leung WK; Bai AH; Chan VY; Yu J; Chan MW; To KF; Wu JR; Chan KK; Fu YG; Chan FK; Sung JJ
Gut; 2004 Mar; 53(3):331-8. PubMed ID: 14960510
[TBL] [Abstract][Full Text] [Related]
14. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
Williams CS; Goldman AP; Sheng H; Morrow JD; DuBois RN
Neoplasia; 1999 Jun; 1(2):170-6. PubMed ID: 10933052
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer.
Babbar N; Ignatenko NA; Casero RA; Gerner EW
J Biol Chem; 2003 Nov; 278(48):47762-75. PubMed ID: 14506281
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
17. [Nonsteroidal anti-rheumatic drugs and colon carcinoma: COX versus PPAR].
Wächtershäuser A; Stein J
Z Gastroenterol; 1999 Mar; 37(3):257-61. PubMed ID: 10234800
[No Abstract] [Full Text] [Related]
18. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P
Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
Subbaramaiah K; Lin DT; Hart JC; Dannenberg AJ
J Biol Chem; 2001 Apr; 276(15):12440-8. PubMed ID: 11278336
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.
Jaradat MS; Wongsud B; Phornchirasilp S; Rangwala SM; Shams G; Sutton M; Romstedt KJ; Noonan DJ; Feller DR
Biochem Pharmacol; 2001 Dec; 62(12):1587-95. PubMed ID: 11755111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
